Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0PZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,772
Award facts
- Contract value 100% obligated
- $11,772.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,772.18 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The pharmaceutical distributor will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, reflecting the federal government's procurement of specialty pharmaceuticals for military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's substantial $999,999,999.00 prime IDC vehicle with DLA, which runs through December 2026 and supports global pharmaceutical supply for military healthcare programs. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The company's consistent receipt of competitively awarded contracts demonstrates its capability to meet federal procurement requirements across the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FA0PZ?
SPE2DR26FA0PZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FA0PZ worth?
The government has obligated $11,772 on SPE2DR26FA0PZ.
Is contract SPE2DR26FA0PZ an order under another contract?
Yes. SPE2DR26FA0PZ is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0PZ competed?
The extent of competition for SPE2DR26FA0PZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award